Risk stratification in patients with structurally normal hearts: does fibrosis type matter?

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Assistant Professor Katarzyna Gil

The Ohio State University, Columbus (United States of America)

7 More presentations in this session

Presentation thumbnail

Prognostic value of left ventricular hypertrophy in patients with myocardial fibrosis by ECV mapping on cardiac MRI

Doctor L. Alam (New York City, US)

Abstract Slides Video

Presentation thumbnail

Cardiac troponin T and I are differentially associated with myocardial fibrosis assessed by cardiac magnetic resonance imaging

Doctor M. Paus (Oslo, NO)

Abstract Slides Video

Presentation thumbnail

Left ventricular fibrosis influences the time to recovery in patients with arrhythmia-induced cardiomyopathy

Doctor D. Lavall (Leipzig, DE)

Abstract Slides Video

Presentation thumbnail

Association of late-gadolinium enhancement on cardiac magnetic resonance with cardiovascular outcomes and mortality in patients with aortic stenosis

Doctor S. Moussa (Stony Brook, US)

Abstract Slides Video

Presentation thumbnail

Association of epicardial adipose tissue on magnetic resonance imaging with cardiovascular outcomes: Quality over quantity?

Doctor F. Duca (Vienna, AT)

Abstract Slides Video

Access the full session

Session thumbnail

CMR tissue characterisation: why it matters

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

Cardiac magnetic resonance imaging in the work-up and management of cardiac amyloidosis

Congress Presentation

Comparative assessment of CMR-determined extracellular volume metrics in predicting adverse outcomes

Congress Presentation

CMR for inflammation, oedema, and the pericardium

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources